Not the strongest arguments: an ad hominem attack on my figurative vision, and calling a study "badly designed" because it contradicts the few random lab tests on which you base some flawed assumptions. As a reminder, this particular study was a Phase II clinical trial that had to pass muster with an FDA that's been skeptical of testosterone-based products.
Then there's the mischaracterization of what I said in order to create a straw man. I did not say that IM and SQ create identical serum testosterone curves, nor did I say that subjective results would be the same. The evidence suggests that generally IM creates higher peaks and lower troughs in both testosterone and estradiol. It's quite plausible that this can result in subjective differences.